Table: Aska Pharmaceutical -2015/16 parent results

ASKA Pharmaceutical Holdings

12/05/2016 07:00

May 12 (Reuters)-  
          Aska Pharmaceutical Co Ltd  
          PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended       Year to     NEXT      
              Mar 31, 2016    Mar 31, 2015   Mar 31, 2017     YEAR      
                 LATEST         YEAR-AGO        COMPANY      COMPANY    
                 RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales           39.53           40.52                                 
               (-2.4 pct)      (+3.1 pct)                               
  Operating      869 mln           1.45                                 
               (-39.9 pct)    (+142.7 pct)                              
  Recurring        1.23            1.75                                 
               (-29.9 pct)     (+87.4 pct)                              
  Net            404 mln           1.25                                 
               (-67.6 pct)    (+177.9 pct)                              
  EPS           14.38 yen       44.46 yen                               
  Ann Div       14.00 yen       14.00 yen      14.00 yen                
  -Q2 Div       7.00 yen        7.00 yen       7.00 yen                 
  -Q4 Div       7.00 yen        7.00 yen       7.00 yen                 
   
  NOTE - Aska Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4514.T 
  ((Tokyo Headline News Desk +813 6441 1812))